Shot chasers: big pharmas covid-19 boost

Published: May 26, 2020, 10:08 a.m.

b'

The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory\\u2019s increasingly fraught politics. 

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer



Hosted on Acast. See acast.com/privacy for more information.

'